Trials / Recruiting
RecruitingNCT06789484
Characterization of the Gastrointestinal Microbiota in Newborn Infants
Recovery of a Probiotic in Term Newborns - a Randomized, Double-blinded, Placebo-controlled Proof-of-concept Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 1 Day
- Healthy volunteers
- Accepted
Summary
The BABIES study is a single-center, randomized, double-blinded, placebo-controlled study in newborns with a 4-week intervention period from birth to 28 days of life followed by a 2-week follow-up period (Figure 1). The study will evaluate the seeding ability of supplementation with a probiotic strain. The aim is to investigate the recovery and engraftment of the probiotic strain in infant fecal samples after 4 weeks supplementation using a strain specific quantitative Polymerase Chain Reaction (qPCR).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Probiotic | Given daily from enrollement to 28 days of life |
| DIETARY_SUPPLEMENT | Placebo | Given daily from enrollement to 28 days of life |
Timeline
- Start date
- 2025-03-04
- Primary completion
- 2025-10-30
- Completion
- 2025-12-31
- First posted
- 2025-01-23
- Last updated
- 2025-04-13
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06789484. Inclusion in this directory is not an endorsement.